Design and synthesis of potent bivalent peptide agonists targeting the EphA2 receptor

ACS Medicinal Chemistry Letters

Volumn 4, Issue 3, 2013, Pages 344-348

  Duggineni, Srinivas ^a   Mitra, Sayantan ^b   Lamberto, Ilaria ^b   Han, Xiaofeng ^a   Xu, Yan ^a   An, Jing ^a   Pasquale, Elena B ^b,c   Huang, Ziwei ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b BURNHAM INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Eph receptors; peptide inhibitors; protein protein interactions; structure based drug design

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; EPHRIN RECEPTOR A2; SWL PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL CULTURE; DRUG DESIGN; DRUG SYNTHESIS; ENZYME ACTIVATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

EID: 84875147480     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml3004523     Document Type: Article

References (26)

1. Pasquale, E. B. Eph-ephrin bidirectional signaling in physiology and disease Cell 2008, 133, 38-52 (Pubitemid 351442996)
2. Pasquale, E. B. Eph receptors and ephrins in cancer: Bidirectional signalling and beyond Nat. Rev. Cancer 2010, 10, 165-180
3. Biao-Xue, R.; Xi-Guang, C.; Shuan-Ying, Y.; Wei, L.; Zong-Juan, M. EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors Curr. Cancer Drug Targets 2011, 11, 1082-1097
4. Tandon, M.; Vemula, S. V.; Mittal, S. K. Emerging strategies for EphA2 receptor targeting for cancer therapeutics Expert Opin. Ther. Targets 2011, 15, 31-51
5. Wykosky, J.; Debinski, W. The EphA2 receptor and ephrinA1 ligand in solid tumors: Function and therapeutic targeting Mol. Cancer Res. 2008, 6, 1795-1806
6. Miao, H.; Wei, B. R.; Peehl, D. M.; Li, Q.; Alexandrou, T.; Schelling, J. R.; Rhim, J. S.; Sedor, J. R.; Burnett, E.; Wang, B. C. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway Nat. Cell Biol. 2001, 3, 527-530 (Pubitemid 32422092)
7. Koolpe, M.; Dail, M.; Pasquale, E. B. An ephrin mimetic peptide that selectively targets the EphA2 receptor J. Biol. Chem. 2002, 277, 46974-46979 (Pubitemid 36159202)
8. Miao, H.; Li, D. Q.; Mukherjee, A.; Guo, H.; Petty, A.; Cutter, J.; Basilion, J. P.; Sedor, J.; Wu, J.; Danielpour, D.; Sloan, A. E.; Cohen, M. L.; Wang, B. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt Cancer Cell 2009, 16, 9-20
9. Mitra, S.; Duggineni, S.; Koolpe, M.; Zhu, X.; Huang, Z.; Pasquale, E. B. Structure-activity relationship analysis of peptides targeting the EphA2 receptor Biochemistry 2010, 49, 6687-6695
10. Yang, N. Y.; Fernandez, C.; Richter, M.; Xiao, Z.; Valencia, F.; Tice, D. A.; Pasquale, E. B. Crosstalk of the EphA2 receptor with a serine/threonine phosphatase suppresses the Akt-mTORC1 pathway in cancer cells Cell Signal 2011, 23, 201-212
11. Udayakumar, D.; Zhang, G.; Ji, Z.; Njauw, C. N.; Mroz, P.; Tsao, H. Epha2 is a critical oncogene in melanoma Oncogene 2011, 30, 4921-4929
12. Hess, A. R.; Seftor, E. A.; Gardner, L. M.; Carles-Kinch, K.; Schneider, G. B.; Seftor, R. E.; Kinch, M. S.; Hendrix, M. J. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: Role of epithelial cell kinase (Eck/EphA2) Cancer Res. 2001, 61, 3250-3255 (Pubitemid 32695007)
13. Margaryan, N. V.; Strizzi, L.; Abbott, D. E.; Seftor, E. A.; Rao, M. S.; Hendrix, M. J.; Hess, A. R. EphA2 as a promoter of melanoma tumorigenicity Cancer Biol. Ther. 2009, 8, 279-288
14. Brantley, D. M.; Cheng, N.; Thompson, E. J.; Lin, Q.; Brekken, R. A.; Thorpe, P. E.; Muraoka, R. S.; Cerretti, D. P.; Pozzi, A.; Jackson, D.; Lin, C.; Chen, J. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo Oncogene 2002, 21, 7011-7026 (Pubitemid 35252975)
15. Brantley-Sieders, D. M.; Caughron, J.; Hicks, D.; Pozzi, A.; Ruiz, J. C.; Chen, J. EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activation J. Cell Sci. 2004, 117, 2037-2049 (Pubitemid 38745137)
16. Wykosky, J.; Gibo, D. M.; Debinski, W. A novel, potent, and specific ephrinA1-based cytotoxin against EphA2 receptor expressing tumor cells Mol. Cancer Ther. 2007, 6, 3208-3218
17. Jackson, D.; Gooya, J.; Mao, S.; Kinneer, K.; Xu, L.; Camara, M.; Fazenbaker, C.; Fleming, R.; Swamynathan, S.; Meyer, D.; Senter, P. D.; Gao, C.; Wu, H.; Kinch, M.; Coats, S.; Kiener, P. A.; Tice, D. A. A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo Cancer Res. 2008, 68, 9367-9374
18. Lee, J. W.; Han, H. D.; Shahzad, M. M.; Kim, S. W.; Mangala, L. S.; Nick, A. M.; Lu, C.; Langley, R. R.; Schmandt, R.; Kim, H. S.; Mao, S.; Gooya, J.; Fazenbaker, C.; Jackson, D.; Tice, D. A.; Landen, C. N.; Coleman, R. L.; Sood, A. K. EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma J. Natl. Cancer Inst. 2009, 101, 1193-1205
19. Dickerson, E. B.; Blackburn, W. H.; Smith, M. H.; Kapa, L. B.; Lyon, L. A.; McDonald, J. F. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery BMC Cancer 2010, 10, 10
20. Wang, S.; Placzek, W. J.; Stebbins, J. L.; Mitra, S.; Noberini, R.; Koolpe, M.; Zhang, Z.; Dahl, R.; Pasquale, E. B.; Pellecchia, M. A novel targeted system to deliver chemotherapeutic drugs to EphA2-expressing cancer cells J. Med. Chem. 2012, 55, 2427-2436
21. Wang, S.; Noberini, R.; Stebbins, J. L.; Das, S.; Zhang, Z.; Wu, B.; Mitra, S.; Billet, S.; Fernandez, A.; Bhowmick, N. A.; Kitada, S.; Pasquale, E. B.; Fisher, P. B.; Pellecchia, M. Targeted delivery of paclitaxel to EphA2-expressing cancer cells Clin. Cancer Res. 2013, 19, 128-137
22. Cai, W.; Ebrahimnejad, A.; Chen, K.; Cao, Q.; Li, Z. B.; Tice, D. A.; Chen, X. Quantitative radioimmunoPET imaging of EphA2 in tumor-bearing mice Eur. J. Nucl. Med. Mol. Imaging 2007, 34, 2024-2036 (Pubitemid 350212123)
23. Himanen, J. P.; Yermekbayeva, L.; Janes, P. W.; Walker, J. R.; Xu, K.; Atapattu, L.; Rajashankar, K. R.; Mensinga, A.; Lackmann, M.; Nikolov, D. B.; Dhe-Paganon, S. Architecture of Eph receptor clusters Proc. Natl. Acad. Sci. U.S.A. 2010, 107, 10860-10865
24. Seiradake, E.; Harlos, K.; Sutton, G.; Aricescu, A. R.; Jones, E. Y. An extracellular steric seeding mechanism for Eph-ephrin signaling platform assembly Nat. Struct. Mol. Biol. 2012, 17, 398-402
25. Lackmann, M.; Mann, R. J.; Kravets, L.; Smith, F. M.; Bucci, T. A.; Maxwell, K. F.; Howlett, G. J.; Olsson, J. E.; Bos, T. V.; Cerretti, D. P.; Boyd, A. W. Ligand for Eph-related kinase (LERK) 7 is the preferred high affinity ligand for the HEK receptor J. Biol. Chem. 1997, 272, 16521-16530 (Pubitemid 27276480)
26. Pabbisetty, K. B.; Yue, X.; Li, C.; Himanen, J. P.; Zhou, R.; Nikolov, D. B.; Hu, L. Kinetic analysis of the binding of monomeric and dimeric ephrins to Eph receptors: correlation to function in a growth cone collapse assay Protein Sci. 2007, 16, 355-361 (Pubitemid 46327546)